Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about LRP3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | LRP3 |
| Full Name | Low Density Lipoprotein Receptor-Related Protein 3 |
| Chromosome | 19q13.31 |
| Protein Family | LDLR receptor family |
| Protein Type | Receptor |
| Function | LRP-family proteins typically combine extracellular ligand-binding domains with transmembrane and cytoplasmic motifs that support ligand uptake, trafficking, and downstream signaling.[@herz2001] Withi |
| Primary Expression | Brain (cortex, hippocampus), heart, skeletal muscle |
| Molecular Weight | 250 kDa |
| Amino Acids | 325 aa |
| UniProt ID | O75074 |
| NCBI Gene ID | 4037 |
| Ensembl ID | ENSG00000186603 |
| GeneCards | LRP3 |
| Human Protein Atlas | LRP3 |
| Transmembrane domain | Single pass membrane-spanning region |
| Associated Diseases | neurodegeneration |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
LRP3["LRP3"]
neurodegeneration["neurodegeneration"]
LRP3 -->|"implicated_in"| neurodegeneration
style LRP3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neuroscience | 2026-04-04 | 7 hypotheses Top: 0.679
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Molecular characterization of RBG-NLRP3 binding interaction | exploratory | atherosclerosis | 0.900 | 0.00 | purified proteins and molecula | proposed | N/A |
| Leukocyte gene expression analysis in COVID-19 patients | exploratory | COVID-19 | 0.900 | 0.00 | human leukocytes from COVID-19 | proposed | N/A |
| RBG effects on macrophage polarization and foam cell formation | exploratory | atherosclerosis | 0.850 | 0.00 | primary macrophages | proposed | N/A |
| Transcriptomic analysis of RBG effects on inflammatory gene expression | exploratory | atherosclerosis | 0.800 | 0.00 | ApoE-/- mice and cell cultures | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Interaction between autophagy and the NLRP3 inflammasome in Alzheimer's and Park [PMID:36262883] | Unknown | Frontiers in aging neuroscienc | 2023 | 0 |
| Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438] | Hegdekar N, Sarkar C, Bustos S, Ritzel R | Autophagy | 2023 | 0 |
| Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's [PMID:37029500] | Yan YQ, Zheng R, Liu Y, Ruan Y, Lin ZH, | Aging cell | 2023 | 0 |
| Microglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like [PMID:36288697] | Li S, Fang Y, Zhang Y, Song M, Zhang X, | Cell reports | 2022 | 0 |
| Biomarker of Neuroinflammation in Parkinson's Disease. [PMID:35456966] | Liu TW, Chen CM, Chang KH | Int J Mol Sci | 2022 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| NLRP3 inflammasome activation drives tau pathology. [PMID:31748742] | ["Ising C", "Venegas C", "Zhang S", "Sch | Nature | 2019 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
| Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodeg [PMID:30381407] | Gordon R, Albornoz EA, Christie DC, Lang | Science translational medicine | 2018 | 0 |
| NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS [PMID:23254930] | Heneka MT, Kummer MP, Stutz A, Delekate | Nature | 2013 | 0 |
| NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS [PMID:23254930] | ["Heneka Michael T", "Kummer Markus P", | Nature | 2013 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning LRP3 in their description or question text
Score: 0.720 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The NLRP3 (NACHT, LRR and PYD domains-containing protein 3) inflammasome represen
Score: 0.681 · neuroinflammation · 2026-04-12
## Mechanistic Overview NLRP3/Mitophagy Coupling Modulation starts from the claim that modulating NLRP3 within the disea
Score: 0.631 · neuroinflammation · 2026-04-21
**Molecular Mechanism and Rationale** The C1Q complement system component represents a critical bridge between innate i
Score: 0.625 · neuroscience · 2026-04-22
**Molecular Mechanism and Rationale** Galectin-3 (LGALS3) functions as a critical molecular sensor and platform orchest
Score: 0.620 · neurodegeneration · 2026-04-26
Gut-derived bacterial components (LPS, MDP) provide Signal 1 for NLRP3 inflammasome priming via TLR4/TLR2/NOD2, inducing
Score: 0.620 · neuroscience · 2026-04-22
## Mechanistic Overview Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 inflammasome activati
Score: 0.617 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The proposed LRP1/NLRP3/IL-1β cascade represents a critical mechanistic link betw
Score: 0.610 · neurodegeneration · 2026-04-24
Physiological SCFA elevation may generate a weak, context-dependent signal that is insufficient alone but could become b
Score: 0.610 · neurodegeneration · 2026-04-28
NLRP3 inflammasome activation releases IL-1β, driving complement cascade upregulation and synapse elimination. MCC950 or
Score: 0.590 · neurodegeneration · 2026-04-25
This hypothesis proposes that HBOT reduces ROS-mediated NF-κB activation and NLRP3 inflammasome assembly, promoting anti
Score: 0.580 · neuroscience · 2026-04-22
## Mechanistic Overview LAMP-2 replacement therapy prevents lysosomal membrane permeabilization and downstream NLRP3 act
Score: 0.570 · neuroinflammation · 2026-04-22
## Mechanistic Overview CX3CR1-Negative Trem2-High Microglial Subset Mediates Female Resilience via Estrogen Receptor-al
Score: 0.566 · developmental-neurobiology · 2026-04-21
## Mechanistic Overview NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumulation starts from the claim that mod
Score: 0.566 · neurodegeneration · 2026-04-16
## Mechanistic Overview NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplification starts from t
Score: 0.563 · biomarkers · 2026-04-22
## Mechanistic Overview P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming starts from the claim that modulatin